Cabaletta Bio Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.4% | +17.0% | +8.4% | -0.5% | +10.4% | +3.6% | -3.5% | -26.3% | +0.9% | -3.2% | +1,192.6% | – | |
| – | +1.4% | +24.3% | +32.2% | +4.7% | +3.1% | -4.6% | +10.5% | +1.9% | -26.8% | +23.4% | +4.6% | – | |
| – | +19.3% | -731.5% | – | – | -0.8% | -206.0% | – | -94.7% | -849.8% | – | – | – | |
| – | +184.6% | +338.9% | -5.2% | -67.1% | +48.6% | +108.8% | -79.5% | -51.6% | +162.8% | -100.0% | – | – | |
| – | – | -171.5% | – | -48.4% | -1.0% | -106.5% | +6,167.0% | +1.8% | – | +2.3% | – | – | |
| – | – | – | – | – | +8.5% | – | – | – | +47.7% | – | – | – | |
| – | – | – | – | – | – | – | +443.8% | -73.5% | +140.5% | +123.4% | -34.0% | – | |
| – | +94,848.0% | -92.6% | -94.5% | -81.3% | +6,057.7% | -112.6% | – | -100.9% | – | +203.3% | +493.6% | – | |
| – | – | -123.1% | – | -341.1% | – | – | – | -719.7% | – | +47.8% | +222.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.